About the Authors

  • The Authors and Contributors of "Patent Docs" are patent attorneys and agents, many of whom hold doctorates in a diverse array of disciplines.
2018 Juristant Badge - MBHB_165
Juristat #4 Overall Rank

E-mail Newsletter

  • Enter your e-mail address below to receive the "Patent Docs" e-mail newsletter.

Enter your email address:

Delivered by FeedBurner

Contact the Docs

Docs on Twitter


Disclaimer

  • "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.
Juristat_165
Juristat #8 Overall Rank

Pharma-50-transparent_216px_red

« CVC Reply No. 2 to Broad's Opposition No. 2 to CVC's Motion No. 2 to Be Accorded Benefit of Priority | Main | CVC Files Motion to Exclude Broad Evidence; Broad Opposes »

April 15, 2020

Comments

A quick check on the esp@cenet database reveals that although there was a PCT application, no attempt was made to regionalize the case at the EPO. Given the EPO approach to eligibility that is hardly surprising!

Mr. Cole,

I am not sure what you think that your point is. That different Sovereigns have chosen different rules and that a rule against business methods per se in one Sovereign somehow excuses another Sovereign from following their own differently selected rules that allow business methods?

Here, wear my glasses, they work for me. What? They do not work for you? What is wrong with you?

Paul, I see that there is a grant in Canada, but I see none anywhere outside North America, despite Applicant going the PCT route and despite there being an A publication in Australia.

So what of value does that tell us about variations in patent eligibility, all round the world, these days?

The comments to this entry are closed.

March 2021

Sun Mon Tue Wed Thu Fri Sat
  1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30 31